Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 171.43B | 115.11B | 114.73B | 113.61B | 108.52B | 100.72B |
Gross Profit | 121.06B | 70.37B | 49.77B | 63.56B | 61.70B | 58.81B |
EBITDA | 55.24B | 53.74B | 43.07B | 44.48B | 40.14B | 39.41B |
Net Income | 12.07B | 11.21B | 17.79B | 8.00B | 6.10B | 6.75B |
Balance Sheet | ||||||
Total Assets | 304.98B | 304.93B | 290.31B | 298.59B | 281.63B | 264.92B |
Cash, Cash Equivalents and Short-Term Investments | 21.65B | 8.37B | 7.28B | 5.62B | 6.01B | 12.94B |
Total Debt | 148.55B | 145.15B | 138.75B | 147.75B | 142.07B | 137.26B |
Total Liabilities | 207.20B | 206.29B | 199.07B | 211.27B | 200.16B | 192.37B |
Stockholders Equity | 64.08B | 63.30B | 56.92B | 48.56B | 42.68B | 35.92B |
Cash Flow | ||||||
Free Cash Flow | 22.50B | 20.70B | 19.43B | 11.71B | 5.81B | 5.05B |
Operating Cash Flow | 41.43B | 39.87B | 37.30B | 35.82B | 32.17B | 23.74B |
Investing Cash Flow | -19.61B | -18.90B | -10.21B | -22.31B | -27.40B | -22.65B |
Financing Cash Flow | -15.64B | -20.28B | -25.53B | -15.44B | -10.78B | 7.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $186.53B | 10.28 | 18.26% | 6.03% | 2.05% | 61.39% | |
80 Outperform | $286.57B | 24.01 | 19.74% | 1.27% | 6.27% | 31.78% | |
78 Outperform | $179.66B | 13.01 | 20.81% | 2.74% | 4.64% | 156.88% | |
77 Outperform | $206.43B | 16.46 | 12.12% | 3.83% | 1.46% | 0.88% | |
60 Neutral | $28.08B | 9.21 | -7.17% | 4.23% | 0.89% | -494.16% | |
60 Neutral | $31.64B | ― | -3.55% | 6.31% | -4.73% | -251.31% | |
56 Neutral | C$4.28B | 1.82 | -13.65% | 5.28% | -5.80% | -53.72% |